Introduction
The serotonergic system modulates diverse physiological and behavioral functions, such as sleep, feeding, nociception, mood, and emotions (Lucki, 1998) . Serotonergic dysfunction has been implicated in a variety of psychiatric disorders, including depression, anxiety, schizophrenia, Parkinson's disease, and Alzheimer disease (Meltzer et al., 1998; Jones and Blackburn, 2002; Huot et al., 2011) . The majority of serotonergic neurons are found in the dorsal and medial raphe nuclei, sending widespread projections to many brain regions including the auditory system (Dahlström and Fuxe, 1964; Steinbusch, 1981; Descarries et al., 1982) , with dense innervation in the cochlear nucleus (Steinbusch, 1981; Thompson and Thompson, 2001) . Although the physiological function of 5-HT in the auditory system is unclear, it may differentially modulate the response to simple and complex sounds such as vocalizations (Ebert and Ostwald, 1992; Revelis et al., 1998; Hurley and Pollak, 1999, 2005; Hurley and Hall, 2011; Wood et al., 2013) . Dysfunction of the serotonergic system is implicated in the generation or perception of tinnitus (Marriage and Barnes, 1995; Simpson and Davies, 2000; Salvinelli et al., 2003; Caperton and Thompson, 2010) . Moreover, it has been suggested that selective 5-HT reuptake inhibitors (SSRIs) often used in the treatment of depression and anxiety disorders (Stark et al., 1985; , might be also used to treat tinnitus (Shemen, 1998; Folmer and Shi, 2004; Fornaro and Martino, 2010; Oishi et al., 2010; Baldo et al., 2012) . Therefore, understanding the normal physiological effects of 5-HT in auditory system may provide insight into normal brain function and suggest new approaches in the treatment of tinnitus.
The role of 5-HT in auditory system may be of particular interest in the dorsal cochlear nucleus (DCN), where auditory and multisensory signals converge at fusiform principal cells. Among proposed functions of the DCN is sound source localization and orientation to sounds of interest (Sutherland et al., 1998; Imig et al., 2000; May, 2000; Oertel and Young, 2004) , and is a proposed site of central tinnitus generation and modulation (Levine, 1999; Brozoski et al., 2002 Brozoski et al., , 2012 Kaltenbach et al., 2004; Wang et al., 2009; Middleton et al., 2011; Dehmel et al., 2012; Koehler and Shore, 2013; Li et al., 2013; Luo et al., 2014) . Moreover, the DCN receives a dense serotonergic innervation, originating predominantly from the dorsal and medial raphe nuclei (Parent et al., 1981; Steinbusch, 1981; Willard et al., 1984; Klepper and Herbert, 1991; Thompson et al., 1994 Thompson et al., , 1995 Hurley and Thompson, 2001; Thompson and Thompson, 2001) , and contains multiple subtypes of 5-HT receptors, including 5-HT 1A R, 5-HT 2A R, and 5-HT 2C R (Pazos et al., 1985; Thompson et al., 1994; Cornea-Hébert et al., 1999; Thompson and Wiechmann, 2002) , and measureable levels of 5-HT (Cransac et al., 1995) . Yet, despite the potential physiological functions of serotonergic raphe-DCN pathway, it is unclear what 5-HT does in the DCN. Here, we found that 5-HT activates 65-80% and membrane potential was held constant at Ϫ70 mV except for experiments shown in Figure 4 . Experiments were excluded if series resistance varied Ͼ20% over the course of the recording. In currentclamp recordings, the pipette capacitance was canceled and bridge balance was maintained.
For microiontophoresis, methods were similar to a previous study (Perrier and Cotel, 2008) : a micropipette (40 -80 M⍀) was filled with 50 -100 mM serotonin hydrochloride dissolved in 165 mM NaCl, and the pH adjusted to 4.5 using HCl. Retaining current of Ϫ20 nA were applied to micropipette to reduce drug leakage between ejection periods. 5-HT was ejected by applying positive currents (ϩ40 -80 nA) for 3-5 s. In control experiments, iontophoresis of drug carrier saline (165 mM NaCl) alone failed to evoke any detectable currents using the same iontophoresis current level as using those to eject 5-HT. The micropipette was positioned close to the soma of the recorded neurons.
Optogenetic stimulation was performed as previously described (Apostolides and Trussell, 2013) . Briefly, wide-field activation of ChR2 was achieved with blue light from a LED (470 nm) transmitted through the fluorescent light path of the microscope. Photostimulation was delivered at 3 min intervals, and the maximal light intensity reaching the brain slice was ϳ15 mW/mm 2 . Data acquisition and analysis. Data were collected using a Multiclamp 700B amplifier and pClamp 10 software (Molecular Devices). Signals were digitized at 10 -50 kHz with a Digidata 1322A (Molecular Devices) and low-pass filtered at 1-10 kHz for offline analysis.
To assess the effects of 5-HT on activation parameters of I h , an activation curve was obtained by fitting averaged normalized I h currents with a Boltzmann equation of the form I/I max ϭ 1/[1 ϩ exp(V m Ϫ V 1/2 )/s] in which I/I max is the normalized current, V m is the membrane potential, V 1/2 is the potential at half-maximal conductance and s is the slope factor. The time constant of I h activation was determined by fitting the currents evoked by a step to Ϫ80 or Ϫ90 mV potential with a double-exponential function of the form: I t ϭ I ss ϩ I fast ϫ exp(Ϫt/ fast ) ϩ I slow ϫ exp(Ϫt/ slow ), where I t is the current amplitude at time t, I ss is the steady-state current at a given potential, I fast and I slow denote the amplitude of the slow and fast current components, and fast and slow are the corresponding time constants for I h activation.
All data are presented as mean Ϯ SEM unless specified otherwise, and statistical significance was assessed using Student's t tests as appropriate; *p Ͻ 0.05, **p Ͻ 0.01 and ***p Ͻ 0.001.
Immunohistochemistry. Tph2-ChR2 transgenic mice (P20 -P30) were deeply anesthetized with isoflurane and were transcardially perfused with warm (ϳ38C°) PBS, pH 7.4, followed by ice-cold 4% paraformaldehyde (PFA) in PBS. After perfusion, mouse brains were dissected out and postfixed in 4% PFA overnight at 4°C. The brains were rinsed thoroughly in PBS, pH 7.4, embedded in 4% agar, and sliced into 30 m coronal sections using a vibratome (Leica VT1000S). Next, sections were washed in PBS for 30 min and subsequently permeabilized in 1% Triton X-100 in PBS for 1 h. After again being washed in PBS for 30 min, sections were incubated for 30 min in blocking solution consisting 2% fish gelatin in PBS. The sections were then incubated with anti-GFP AlexaFluor 488-conjugated antibody (10 g/ml; Invitrogen) in blocking solution overnight at 4°C. After being washed in PBS for 30 min, sections were postfixed in 4% PFA for 1 h. After being washed again in PBS, sections were then mounted on slides and coverslipped with mounting medium. Images were acquired using laser-scanning confocal microscopy (Olympus FV1000).
Reagents. 5-HT was applied by either bath application or iontophoresis, and all other drugs were applied either in the bath or through the recording pipette. NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo-[f]quinoxaline-7-sulfonamide), R-CPP ((R)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid), SR95531 (Gabazine), and TTX (tetrodotoxin) were obtained from Abcam. 5-HT (serotonin hydrochloride), ketanserin, MDL-11939, SB-242084, ␣-methyl-5-HT, SB-269970, WAY-100135, ZD7288, SQ22536, 8-Br-cAMP, PKC 19-31 , genistein, PP1 (1-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazolo [3,4-d] pyrimidin-4-amine), and PP2 (3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo [3,4-d] pyrimidin-4-amine) were purchased from Tocris Bioscience. All other drugs and chemicals were from Sigma-Aldrich.
Results

5-HT regulates excitability of fusiform cells
To explore the effects of 5-HT in DCN, whole-cell and loose cell-attached recordings were obtained from acute slices of mouse brainstem containing DCN. Under current-clamp, bath application of 10 M 5-HT produced a significant depolarization of the resting membrane potential (control: Ϫ68.1 Ϯ 1.5 mV, 5-HT: Ϫ63.0 Ϯ 1.4 mV; p Ͻ 0.001, paired t test, n ϭ 8). This depolarization led to enhancement of spontaneous spike activity (control: 0.2 Ϯ 0.1 Hz, 5-HT: 3.9 Ϯ 1.1 Hz; p Ͻ 0.01, n ϭ 10; Fig.  1 A, B) . These (and subsequent) experiments were performed in the presence of blockers of ionotropic glutamate receptors, GABA A receptors, and glycine receptors, except as otherwise noted, and thus the excitatory actions of 5-HT are likely to be postsynaptic in nature. Moreover, the depolarization produced by 5-HT persisted in the presence of 1 M TTX or blockers of synaptic transmission, again indicating a postsynaptic mechanism of 5-HT on fusiform cells. The 5-HT-elicited increase in firing rate was reversed by returning the membrane potential to control levels with a negative bias current (data not shown), indicating that it was the 5-HT-induced depolarization that initiated spike firing, probably at a region at or close to the cell body. To examine the nature of 5-HT actions without any disturbance to the intracellular environment, loose cell-attached voltageclamp recordings were performed in fusiform cells. As with whole-cell recording, 5-HT (10 M) significantly increased the spike rate (baseline: 5.2 Ϯ 1.7 Hz, 5-HT, 10.6 Ϯ 2.4 Hz; p Ͻ 0.01, n ϭ 12; Fig. 1C,D) . To examine how 5-HT affects the sensitivity of fusiform cells to current stimuli, a series of 1 s current steps were injected into fusiform cells, starting with Ϫ30 pA and incrementing by 20 pA, and spike rate at each current level was measured with and without 5-HT. These experiments showed that 5-HT shifted the input-output relation to the left in a dose-dependent manner ( Fig.  1 E, F ) . To determine the specificity of this effect we also looked at the action of 5-HT on cartwheel interneurons, which provide potent inhibition to fusiform cells, and found that no detectable effects on spike rate or membrane potential (data not shown).
5-HT-evoked response is mediated by 5-HT 2A/2C R and 5-HT 7 R Consistent with the current-clamp data, fusiform cells voltage-clamped at holding potentials of Ϫ70 mV or close to the resting membrane potential, responded to bath application (1, 5, or 10 M) or iontophoresis (50 mM) of 5-HT with a slow, steady, and reversible inward current (Fig.  2 A, B) . The pharmacological identification of 5-HT receptor subtypes mediating the excitatory effects of 5-HT was investigated by using specific agonists and antagonists for 5-HT receptors in voltageclamped cells. Previous studies have shown that 5-HT can produce a slow depolarization of the resting membrane potential by activation of 5-HT 2 R (5-HT 2 receptor) in cortical neurons (Pierce and Peroutka, 1990; Araneda and Andrade, 1991; Tanaka and North, 1993; Zhang, 2003) . Moreover, 5-HT 2A R and 5-HT 2C R are present in cochlear nucleus (Pazos et al., 1985; Thompson et al., 1994; Cornea-Hébert et al., 1999) , We therefore asked whether these receptors mediate the 5-HT response in DCN. Application of the 5-HT 2A R antagonist ketanserin at 10 M largely blocked the inward current elicited by bath application (10 M) or iontophoresis (50 mM) of 5-HT (control: Ϫ60.2 Ϯ 9.5 pA, ketanserin: Ϫ2.2 Ϯ 2.6 pA; p Ͻ 0.001, n ϭ 9; Fig However, the inward current was not fully blocked by the 5-HT 2A R antagonist MDL-11939 plus 5-HT 2C R antagonist SB-242084 (31.5 Ϯ 13.9% of control, p Ͻ 0.05, n ϭ 3). Previous studies have shown that ketanserin also exhibits affinity for 5-HT 7 R (5-HT 7 receptor) (Shen et al., 1993; Jasper et al., 1997; Adham et al., 1998) . Because ketanserin at high concentration (10 M) could almost completely block the 5-HT-evoked response, we wondered whether ketanserin was also blocking 5-HT 7 R response to 5-HT. Indeed, it is well established that activation of 5-HT 7 R can mediate a depolarizing effect on some central neurons (Cardenas et al., 1999; Chapin and Andrade, 2001a, b; Béïque et al., 2004) . Therefore, we examined the effects of SB-269970, a potent and selective antagonist for 5-HT 7 R, on the 5-HT-evoked current. We found that SB-269970 (1 M) partially suppressed the 5-HT-evoked current (43.9 Ϯ 11.3% of control; p Ͻ 0.01, n ϭ 6; Fig. 2A4 ,C). In addition, coapplication of SB-269970 and MDL-11939 completely blocked the 5-HT current (2.0 Ϯ 9.4% of control; p Ͻ 0.01, n ϭ 4; Fig. 2C ). These data suggest that the 5-HT response results from the coactivation of 5-HT 2A/2C R and 5-HT 7 R. Immunochemical studies have shown that 5-HT 1A R is also expresses in the cochlear nucleus (Pazos et al., 1985; Thompson and Wiechmann, 2002) , although it is unclear in what cell types. However, WAY-100135 (10 M), a selective antagonist for 5-HT 1A R, did not affect the 5-HT current (100.6 Ϯ 15.1% of the control; p Ͼ 0.05, n ϭ 3), suggesting that 5-HT 1A R are not involved in the effects of 5-HT on fusiform cells. Overall, these results indicate that activation of both 5-HT 2A/2C R and 5-HT 7 R result in excitation of fusiform cells. 
HCN channels are the downstream targets of serotonergic signaling
Fusiform cells express a wide array of ion channels, including Na ϩ , Ca 2ϩ , K ir , K A , KCNQ, and HCN channels, the latter being the channel subtype that generates the I h current (Hirsch and Oertel, 1988; Harasztosi et al., 1999; Kanold and Manis, 1999; Molitor and Manis, 2003; Pál et al., 2003; Leao et al., 2012) . To determine what ion channels are responsible for the 5-HT response, the effects of blockers of Na ϩ , Ca 2ϩ , K ϩ , and HCN channels were tested on the 5-HT-induced current. Of these blockers, TTX, Cd 2ϩ , Ba 2ϩ , and XE991 failed to reduce the 5-HT-induced current (data not shown). However, Cs ϩ and ZD7288, selective blockers of HCN channels, completely inhibited the 5-HT response (Fig. 3) . Moreover, bath application of either 2 mM Cs ϩ or 10 M ZD7288 alone induced an outward shift of holding current under voltage-clamp (Fig. 3 A, B) . Because 5-HTR (5-HT receptor) antagonists by themselves had no effect on holding current, this result indicates that HCN channels are active partially at rest, and indeed contribute to the resting membrane potential and regulate the excitability of fusiform cells, consistent with the previous studies (Pál et al., 2003; Apostolides and Trussell, 2014) . We further compared the inward current evoked by 5-HT before and after application of 2 mM Cs ϩ or 10 M ZD7288. The inward current evoked by 5-HT was completely blocked by Cs ϩ (control: Ϫ68.8 Ϯ 19.5 pA, Cs ϩ : Ϫ5.7 Ϯ 2.3 pA; p Ͻ 0.05, n ϭ 5; Fig. 3C ,D) or ZD7288 (control: Ϫ64.3 Ϯ 8.0 pA, 10 min after applying ZD7288: Ϫ2.2 Ϯ 3.0 pA; p Ͻ 0.001, n ϭ 7). Similarly, under current-clamp conditions, bath application of either Cs ϩ or ZD7288 alone caused a hyperpolarization of the membrane potential, and blocked spontaneous spiking firing, and also abolished the effects of 5-HT on the membrane potential or spike activity ( Fig.  3 E, F ). These data indicate that HCN channels are the primary downstream targets for these observed excitatory actions of 5-HT on fusiform cells. We next explored how 5-HT affected the biophysical properties of I h by measuring the voltage dependence of I h from the amplitude of tail current relaxations. The experiments were performed in ACSF that contains 1 M TTX and 200 M Ba 2ϩ , to block Na ϩ channels and inward rectifier K ϩ channels. Activation curves for I h were constructed by applying a series of voltage steps from a holding potential at Ϫ60 mV to various levels to activate I h , and then activation voltage steps were followed by a test pulse to Ϫ75 mV with minimal contamination of the tail currents. The amplitude of tail current is proportional to the level of I h conductance for a given prepulse voltage step. Activation curves for I h were obtained by plotting tail current amplitudes against initial step potential, and then fitting with a Boltzmann function (see Materials and Methods). Application of 10 M 5-HT resulted in a 5.6 mV positive shift of the activation curve of I h on the voltage axis (control: Ϫ93.9 Ϯ 2.2 mV, 5-HT: Ϫ88.3 Ϯ 1.8 mV; p Ͻ 0.05, t test, n ϭ 7; Fig. 4A-C) without significantly affecting the amplitude of maximal tail current (control: Ϫ418.1 Ϯ 84.7 pA, 5-HT: Ϫ439.8 Ϯ 96.6; p Ͼ 0.05, n ϭ 7), suggesting that the enhancement of I h resulted from a shift in the activation properties of the I h , but not from an increase in the maximal level I h activation. Accompanying this shift in the activation curve of I h was a reduction in the time constant for I h activation at any given potential by 5-HT. We characterized this effect of 5-HT by applying a 10 s voltage step to fully activate the I h at Ϫ80 mV and Ϫ90 mV, and then comparing the time constant of I h before and after 5-HT application. The activation time course of I h was significantly faster after applying 5-HT at holding potentials of Ϫ80 mV ( fast control: 695.7 Ϯ 28.3 ms, 5-HT: 538.8 Ϯ 55.7 ms, p Ͻ 0.01; slow control: 5.7 Ϯ 0.9 s, 5-HT: 4.2 Ϯ 0.5 s, p Ͻ 0.05; n ϭ 4; Fig. 4 D, E) , or Ϫ90 mV ( fast control: 544.2 Ϯ 27.6 ms, 5-HT: 421.6 Ϯ 58.6 ms, p Ͻ 0.05; slow control: 4.4 Ϯ 0.3 s, 5-HT: 3.0 Ϯ 0.2 s, p Ͻ 0.01; n ϭ 4). These results indicate that excitation of fusiform cells by 5-HT is accompanied by an acceleration of HCN channel gating and shift in voltage sensitivity.
Serotonergic regulation of excitability is G-proteindependent and involves cAMP and Src kinase signaling pathways
We next determined what signaling pathways couple 5-HTR to I h . Both 5-HT 2A/2C R and 5-HT 7 R are G-protein-coupled receptors (GPCRs). To confirm that G-proteins are required for the 5-HT-induced response, we replaced the GTP in the internal recording solution with 1.5 mM GTP-␥-S, a nonhydrolysable GTP analog that should alter G-proteins signaling and potentially disrupt the ability of 5-HT 2A/2C R and 5-HT 7 R to evoke an inward current. Indeed, in the presence of GTP-␥-S, 5-HT failed to induce an inward current (Ϫ4.8 Ϯ 4.0 pA, n ϭ 7; Fig.  5 A, B) , suggesting that the 5-HT-evoked current is mediated by a G-proteindependent pathway.
5-HT 2A/2C R are known to couple to G q to activate PLC (phospholipase C), leading to the release of IP 3 (inositol-1,4,5-trisphosphate) and DAG (diacylglycerol; Hoyer et al., 1994) . PLCmediated IP 3 might initiate the intracellular Ca 2ϩ release from intracellular endoplasmic reticulum stores, and increase Ca 2ϩ could enhance the I h (Lüthi and McCormick, 1999) . To test this possibility, we determined the effects of intracellular BAPTA on the 5-HT-induced current. When recorded cells were dialyzed with 10 mM BAPTA, 5-HT still induced a robust inward current (Ϫ53.8 Ϯ 15.0 pA, p Ͼ 0.05, unpaired t test, n ϭ 5; Fig. 5 A, B) compared with the control conditions (Ϫ60.6 Ϯ 4.1 pA, n ϭ 35), suggesting a Ca 2ϩ independent pathway. In addition, PLC-mediated DAG might activate the protein kinase C (PKC), and PKC activation could affect the I h (He et al., 2014) . To determine the role of PKC, we included a PKC inhibitor peptide PKC 19 -31 in the recording pipette and waited Ͼ30 min after an establishing whole-cell recording, a procedure that effectively blocks PKC activity in other DCN neurons (Bender et al., 2010) . However, intracellular dialysis with 10 M PKC 19 -31 failed to block the 5-HT-evoked current (Ϫ61.7 Ϯ 9.9 pA, p Ͼ 0.05, unpaired t test, n ϭ 6; Fig. 5 A, B) , compared with the current recorded with normal internal solutions (Ϫ60.6 Ϯ 4.1 pA, n ϭ 35), suggesting that PLC/PKC signaling pathway is not involved in 5-HT 2A/2C R signaling. Altogether, these data suggest that serotonergic signaling in fusiform cells does not require a PLC-mediated pathway.
5-HT 7 R is known to couple to Gs, and stimulation of Gs leads to activation of adenylyl cyclase and consequently an increase in intracellular cAMP (Hoyer et al., 1994) . In addition, it is well known that I h is often sensitive to intracellular cAMP (Banks et al., 1993; He et al., 2014) . Thus, we asked whether intracellular cAMP signaling via activation of 5-HT 7 R is involved in the augmentation of I h . To test this possibility, we examined the effects of inhibitors and activators of the cAMP pathway on the 5-HT current. First, we included in the recording pipette an inhibitor of adenylyl cyclase SQ22536 (1 mM). Under these conditions, the 5-HT current was partially attenuated (Ϫ35.7 Ϯ 8.4 pA, p Ͻ 0.05, unpaired t test, n ϭ 5; Fig. 5 A, B) , compared with control conditions (Ϫ60.6 Ϯ 4.1 pA, n ϭ 35), suggesting a role for adenylyl cyclase. To further investigate whether cAMP is responsible for the effects of 5-HT on the fusiform cells, we examined the effects of a membrane-permeable cAMP analog 8-Br-cAMP, an adenylate cyclase activator, on the 5-HT-evoked current. Bath application of 8-Br-cAMP (0.5-1.0 mM) induced an inward current in most cells recorded, as expected for an activator of I h , and moreover resulted in a large reduction of the 5-HT-induced current (control: Ϫ59.8 Ϯ 8.2 pA, 20 min after applying 8-Br-cAMP: Ϫ11.8 Ϯ 6.8 pA; p Ͻ 0.01, n ϭ 8; Fig. 6 A, D) . These results are consistent with the idea that cAMP signaling pathway is partially involved in the excitatory effects of 5-HT on fusiform cells through activation of 5-HT 7 R.
Previous studies have shown that Src tyrosine kinase activity is involved in 5-HT 2A/2C R signaling (González-Maeso et al., 2007; Lu et al., 2008; Schmid and Bohn, 2010; Bigford et al., 2012; Sung et al., 2013) , and that Src tyrosine kinase activity could modulate HCN channels (Zong et al., 2005; Arinsburg et al., 2006; Li et al., 2008) . To examine the possible contribution of Src tyrosine activity to 5-HT signaling in DCN, we assessed the effects of genistein, PP1, and PP2, selective inhibitors for Src kinase, on the 5-HT-induced inward current. Bath application of 30 M genistein, a general inhibitor for Src kinase, partially suppressed the 5-HT-evoked current (74.6 Ϯ 15.5% of control; p Ͻ 0.05, n ϭ 5), suggesting that Src tyrosine kinase activity may be involved in the excitatory effects of 5-HT on fusiform cells. Further evidence consistent with this conclusion comes from the effects of PP1 and PP2 on the 5-HT-induced current. Slices were incubated with either PP1 or PP2 (both 20 M), the selective inhibitors for Src family kinases, before application of 5-HT. Preincubation of PP1 or PP2 for Ͼ1 h reversibly blocked the inward current evoked by 5-HT (PP1 preincubation: Ϫ12.4 Ϯ 3.6 pA, 1 h after wash of PP1: Ϫ43.0 Ϯ 3.7 pA; p Ͻ 0.05, n ϭ 7; PP2 preincubation: Ϫ15.8 Ϯ 3.6 pA, 1 h after wash of PP2: Ϫ38.9 Ϯ 9.7 pA; p Ͻ 0.05, n ϭ 6; Fig.  6B-C,E-F ) . Together, these data suggest that serotonergic regu- lation of neuronal excitability of fusiform cells is G-proteindependent, and involves cAMP and Src signaling-dependent pathways through activation of 5-HT 7 R and 5-HT 2A/2C R, thereby enhancing resting activation of I h .
Stimulation of serotonergic afferents regulates excitability of fusiform cells
While the data so far demonstrate that exogenous 5-HT enhances the excitability of DCN neurons, it is important to ask whether endogenous transmitter released from serotonergic afferent fibers has actions similar to that of exogenous 5-HT. To test this, we took advantage of a Tph2-ChR2-YFP mouse line in which the light activated cation channel ChR2 is expressed selectively in serotonergic neurons (Zhao et al., 2011) . We first confirmed that ChR2-EYFP-positive fibers were present in the DCN by labeling sectioned material with a fluorescent antibody which recognizes EYFP (Zhao et al., 2011; see Materials and Methods) . Fibers were abundantly present in the cell body and deep layers of the DCN, but nearly absent from the molecular layer (Fig. 7 A, B) . A similar pattern of serotonergic innervation of the DCN observed in the Mexican free-tailed bat, labeled fibers are much higher density in fusiform cell layer than in the molecular layer (Hurley and Thompson, 2001 ). In contrast, fibers are densely concentrated in the molecular layer but less heavily in the fusiform cell layer in rat, cat, guinea pig, and opossum (Willard et al., 1984; Klepper and Herbert, 1991; Thompson et al., 1995; Thompson and Thompson, 2001) , suggesting species differences in fiber distribution. Interestingly, label was also absent in the cerebellar molecular layer but apparent in the granule cell region (Fig.  7A) , which is consistent with the observations in some species (Dieudonné, 2001) . We next examined whether optical simulation of serotonergic axonal terminals in brain slices could produce a response in voltage-clamped fusiform cells. Photostimulation with a single 5 ms blue light pulse did not induce detectable responses; however, tetanic photostimulation (20, 50, or 100 Hz, 5 ms light pulses for 10 -20 s) resulted in a slow inward current in a significant fraction of fusiform cells tested (33.3%, 18 of 54 cells; 10 M fluoxetine was added into ACSF solutions to decrease rate of 5-HT clearance in some experiments). This result is consistent with the observation that the 5-HT release by activation of ChR2 depends on the duration of light exposure and light frequency (Dankoski and Wightman, 2013; Dugué et al., 2014; Miyazaki et al., 2014 ). This inward current was markedly reduced by 10 M ketanserin (light stimulus: Ϫ30.1 Ϯ 5.3 pA, ketanserin: Ϫ4.5 Ϯ 3.6 pA; p Ͻ 0.05, n ϭ 4; Fig. 8 A, B) , suggesting that the light-evoked slow responses were mediated by serotonergic transmission. These data also suggest that serotonergic transmission is intrinsically slow, consistent with a idea that 5-HT mostly acts via a volume transmission mode in the CNS (Bunin and Wightman, 1998; Ridet and Privat, 2000; Dieudonné, 2001) . Consistent with this idea, nonjunctional varicosities have been observed in the DCN (Thompson et al., 1995) . More importantly, in some cases, using current-clamp recording, tetanic photostimulation depolarized the cells sufficient to trigger or increases spontaneous spike firing (Fig. 8C) . To further explore the effect of serotonergic axon stimulation on the excitability of fusiform cells, action potentials were elicited by injecting a series of current steps (Ϫ10 to ϩ50 pA, 500 -1000 ms, ⌬I ϭ 20 pA) before and after light stimulus. Photostimulation increased the firing rate upon 10 or 30 pA depolarizing steps in five of eight cells tested (10 pA baseline: 3.2 Ϯ 1.0 Hz, light stim- . 5-HT positively shifts the activation curve for the I h and reduces the time constant for I h activation. A, Sample current traces from a fusiform cell before and after applying 5-HT. Currents were evoked with a series of 5 s voltage steps from Ϫ120 to Ϫ50 mV, in 5 mV increments, from a holding potential of Ϫ60 mV, and followed by a test pulse to Ϫ75 mV. B, Mean normalized tail currents are plotted as a function of voltage steps and fit with the Boltzmann equation (n ϭ 7). Tail currents were measured at Ϫ75 mV in the presence of Ba 2ϩ to eliminate the contamination of K ir . C, Pooled data showing the effects of 5-HT on V 1/2 . Open symbols represent V 1/2 of individual neurons, and filled symbols represent the mean of V 1/2 . D, Superimposition of current traces evoked by 10 s steps to Ϫ80 and Ϫ90 mV from a holding potential of Ϫ60 mV before and after applying 5-HT. E, Pooled data of time constants for I h activation in the absence and presence of 5-HT (n ϭ 4) at two voltages. Error bars are Ϯ SEM. Figure 5 . A G-protein-dependent transduction mechanism. A, Thirty minutes after establishing the whole-cell configuration, application of 10 M 5-HT evoked a response with intracellular perfusions of 1.5 mM GTP-␥-S, 10 mM BAPTA, 10 M PKC 19-31 and 1 mM SQ22536. B, Pooled data for the 5-HT-evoked current under normal internal recording solution (n ϭ 35) or during intracellular dialysis of GTP-␥-S (n ϭ 7), BAPTA (n ϭ 5), PKC 19 -31 (n ϭ 6), and SQ22536 (n ϭ 5). Bars represent mean Ϯ SEM; *p Ͻ 0.05, **p Ͻ 0.01, ***p Ͻ 0.001 (unpaired t test).
ulus: 5.9 Ϯ 1.0 Hz; 30 pA baseline: 9.6 Ϯ 1.7 Hz, light stimulus: 14.2 Ϯ 2.5 Hz; p Ͻ 0.05, n ϭ 5; Fig. 8 D, E) . Thus, these data suggest that 5-HT is released from serotonergic fibers by optical stimulation in the DCN and can regulate the excitability of fusiform cells in a manner similar to that of exogenous 5-HT.
Discussion
Serotonergic regulation of fusiform cells
The DCN is composed of multiple cell types distributed in different sensory processing domains (Oertel and Young, 2004) ; knowing which cells are affected by 5-HT, and how, may allow the functional role of 5-HT to emerge. Serotonergic fibers densely innervate the cell layer that contains fusiform somata, and the molecular and deep layers that contain the dendrites of fusiform cells (Klepper and Herbert, 1991; Thompson et al., 1995; Hurley and Thompson, 2001; Thompson and Thompson, 2001) . We found that after blocking fast synaptic inputs (glutamate, GABA, and glycine), exogenous or endogenous 5-HT depolarized fusiform cells and increased spontaneous spike rate, indicating a direct action on fusiform cell excitability. Therefore, fusiform principal cells in the DCN are a target of serotonergic raphe fibers. Although 5-HT regulates the excitability of fusiform cells by altering their intrinsic properties, it remains to be seen whether 5-HT also modulates synaptic function. Fusiform cells receive excitatory inputs from parallel fibers, auditory nerve and possibly T-stellate cells in the ventral cochlear nucleus (VCN; Oertel et al., 2011) . Given that serotonergic fibers also strongly innervate the granule cell domain and VCN (Klepper and Herbert, 1991; Thompson et al., 1995; Thompson and Thompson, 2001) , and that T-stellate cells are sensitive to 5-HT (Oertel et al., 2011) , 5-HT may also modulate excitatory inputs to fusiform cells. Strong labeling for serotonergic fibers is observed in the DCN region containing inhibitory vertical cells. As serotonergic inputs could potentially contact vertical cells, it will be important to investigate whether 5-HT regulates the activity of vertical cells and their feedforward inhibition to fusiform cells.
Our data indicate that 5-HT 2A/2C R and 5-HT 7 R mediate the effects of 5-HT on fusiform cells. The 5-HT response was partially blocked by the selective 5-HT 2A R antagonist MDL-11939, slightly suppressed by 5-HT 2C R antagonist SB-242084, and partially mimicked by the 5-HT 2 R agonist ␣-methyl-5-HT, indicating that the 5-HT response was partially mediated by some combination of 5-HT 2A/2C R. Although ketanserin at high concentration (10 M) almost completely blocked the response, it may also block 5-HT 7 R (Adham et al., 1998) , suggesting that 5-HT 7 R may contribute to the 5-HT response. Indeed, the 5-HT-response was partially blocked by the 5-HT 7 R antagonist SB-269970, and the remaining currents was suppressed by MDL-11939. In addition, our data show that 8-Br-cAMP partially mimicked and occluded the 5-HT-evoked response, consistent with studies showing that 5-HT 7 R depolarizes neurons through activation of adenylyl cyclase and increase in cAMP (Hoyer et al., 1994) . All these data suggest that the effects of 5-HT on fusiform cells are mediated probably by coactivation of 5-HT 2A/2C R and 5-HT 7 R in individual neurons. In support, 5-HT 2A R and 5-HT 2C R are present in the DCN (Pazos et al., 1985; Thompson et al., 1994; Cornea-Hébert et al., 1999) , and labeling of large, presumptive fusiform cells is apparent in DCN of Htr7-EGFP mice (www.gensat.org). Similar coexpression of 5-HT 2A R and 5-HT 7 R in individual cells has been observed in other central neurons (Béïque et al., 2004; Bonsi et al., 2007) .
Ionic mechanism and signal transduction pathways
Despite the multiplicity of receptors involved in the 5-HT response, HCN channels are likely to be entirely responsible for the resulting enhancement of fusiform cell excitability. Our data show that I h is involved in setting resting potential and ongoing spontaneous firing. Pharmacological block of I h with Cs ϩ or ZD7288 was sufficient to abolish the 5-HT response. 5-HT shifts positively the activation curve for I h without altering maximal activation, thus activating more channels when the cell is at rest. Finally, 5-HT decreased activation time constants for I h . Because I h time constants increase with depolarization (Chen et al., 2001 ), a uniform decrease in time constants implies a rightward shift in the activation curve. Together, I h is the primary downstream target of 5-HT in fusiform cells, as seen in several other regions of the CNS (Bobker and Williams, 1989; Pape and McCormick, 1989; Takahashi and Berger, 1990; Larkman and Kelly, 1992; Cardenas et al., 1999) .
The actions of 5-HT were G-protein-dependent, probably engaging cAMP and Src kinase signaling pathways. 5-HT responses were abolished by GTP-␥-S, which arrests G-protein function. Furthermore, the adenylyl cyclase inhibitor SQ22536 partially blocked the 5-HT response. 8-Br-cAMP evoked an inward current and occluded the 5-HT response. Moreover, 5-HT's effects on I h channel gating mirrored the effects of cAMP on these channels (Chen et al., 2001) . Accordingly, we speculate that 5-HT 7 R could stimulate adenylate cyclase to upregulate intracellular cAMP. Increased cAMP may act directly on HCN, although an additional route involving phosphorylation cannot be excluded here. Intracellular dialysis of BAPTA or PKC 19-31 did not affect the 5-HT current, excluding PLC/IP 3 /Ca 2ϩ and PLC/PKC signaling involvement. Genistein, a tyrosine kinase inhibitor, partially blocked the 5-HT response, and preincubation of the Src kinase inhibitors PP1 or PP2 inhibited the 5-HT response. Thus, activation of 5-HT 2A/2C R may also lead to increased Src kinase activity, and thereby enhance the I h . Notably, Src kinase signaling pathways have been shown to modulate I h in a manner similar to 5-HT and cAMP (Li et al., 2008; He et al., 2014) . All these data suggest that serotonergic signaling in fusiform cells may be mediated by both multiple receptors and multiple signaling pathways.
Functional implications
Given the importance of the DCN in auditory function and tinnitus pathophysiology, the serotonergic regulation of neuronal excitability of the primary output neurons may have important outcomes.
Activation of the serotonergic raphe-DCN pathway could increase excitability and reduce acoustic thresholds of fusiform cells. It may be that this pathway functions as a "gain-setter" in controlling DCN output. Serotonergic neurons in the raphe nuclei fire at 3-5 Hz in quiet, awake animals (Trulson and Jacobs, 1979; Trulson and Trulson, 1982a; Rasmussen et al., 1986) . In addition, the raphe-DCN pathway may be regulated by sensory inputs and behavioral state (Trulson and Trulson, 1982b Bottom trace, This current was blocked by 10 M ketanserin. B, Pooled data show photostimulation-evoked currents were largely blocked by ketanserin (n ϭ 4). C, Example traces from a fusiform cell show that tetanic photostimulation increases the firing rate. D, Representative traces of action potential firing elicited by somatic injection of current pulses (Ϫ10, 10, 30, and 50 pA, 1 s duration) illustrating the effects of photostimulation of serotonergic fibers. E, Pooled data show photostimulation of serotonergic fibers significantly increase the firing rate at 10 or 30 pA depolarizing steps (n ϭ 5).
1998), suggesting that acoustic stimuli might regulate the serotonergic raphe-DCN pathway. Increased activity of serotonergic neurons is associated with behavioral arousal. Thus, 5-HT release in response to sensory stimuli or behavioral events might dynamically regulate the excitability and acoustic threshold of fusiform neurons by modulating their membrane properties.
Aberrant serotonergic transmission at one or more levels in central auditory pathways might play a role in the pathogenesis of tinnitus. Although the mechanisms underlying tinnitus remain unclear, spontaneous hyperactivity in DCN fusiform cells is associated with tinnitus (Kaltenbach et al., 2005; Kaltenbach and Godfrey, 2008; Baizer et al., 2012) . Our data show that 5-HT increases excitability of fusiform cells, and may lead to enhanced downstream excitation, consistent with previous in vivo studies suggesting that 5-HT 2 R and 5-HT 7 R play a role in the regulation of auditory network excitability (Bourson et al., 1997; Brennan et al., 1997; Applegate and Tecott, 1998; Holmes et al., 1998; Oliveira and Zatz, 1999) . Thus, serotonergic dysfunction (e.g., upregulation of 5-HT levels, 5-HTR density or receptor sensitivity to 5-HT) in DCN might contribute to the generation and maintenance of tinnitus (Marriage and Barnes, 1995; Simpson and Davies, 2000; Caperton and Thompson, 2010; Hurley and Hall, 2011; Baizer et al., 2012) . Accordingly, upregulation of extracellular 5-HT levels in DCN increases with noise exposure (Cransac et al., 1998) , which can cause tinnitus (Kaltenbach, 2011) . Notably, in spinal cord, 5-HT2R density and sensitivity to 5-HT can be upregulated following spinal injury (Murray et al., 2010; Husch et al., 2012) . It remains to be investigated whether such modification of serotonergic activity could be induced following cochlear damage. Moreover, SSRIs are commonly used to treat tinnitus in patients with and without depression (Parnes, 1997; Andersson and McKenna, 1998; Folmer and Shi, 2004; Robinson et al., 2007; Fornaro and Martino, 2010; Baldo et al., 2012) ; however, the success of such treatments are inconsistent, and some patients reported a worsening of tinnitus. Acute treatment of SSRIs should increase extracellular concentrations of 5-HT, which based on our study, may then activate 5-HT 2A / 2C R and 5-HT 7 R and enhance DCN output. Responses to pharmaceutical agents may change as transmitter and receptor levels accommodate to the treatment. Thus, activation of 5-HT receptors in fusiform cells may be associated with the onset of a therapeutic response, indeed some patients report tinnitus after beginning SSRIs regiment (Robinson, 2007; Robinson et al., 2007) . Perhaps therapeutic action of SSRIs on tinnitus results from secondary plasticity in 5-HT signaling (e.g., downregulation of 5-HT receptor) induced by boosting serotonergic activity after chronic SSRIs treatment. Indeed, it is well established that a decrease in 5-HT 2A/2C R density can be produced by chronic administration of 5-HT and other 5-HT receptor agonists (Buckholtz et al., 1988; Eison et al., 1989; Anji et al., 2000) , as well as antidepressants (Eison and Mullins, 1996) . Thus, a long-term reduction in 5-HT 2 R density by chronic treatment with SSRIs might play a role in the therapeutic effects of SSRIs in tinnitus. The current study showing the action of 5-HT at a cellular level in the DCN may provide a basis for future studies exploring how SSRIs affect tinnitus.
